Updated: Mar 8, 2022
12-15 April, 2022
Over the years, the synuclein meeting has gained increasing interest and has by now become an established value in the scientific community. The particular meeting concept fosters interactive scientific discussions between early stage and established researchers in an open atmosphere. As such, the synuclein meeting creates a unique opportunity to discuss controversies in the field of synuclein research. During this 2022 edition we will also engage with Parkinson’s disease and Multiple System Atrophy patients and patient organisations to openly discuss on the implications of the synuclein research approaches on their lives and expectations.